Skip to main content
. 2023 May 17;14:1181701. doi: 10.3389/fmicb.2023.1181701

Table 2.

Hyperviscosity phenotype, virulence, and drug resistance genes and capsular serotypes distribution of T6SS-positive and T6SS-negative K. pneumoniae isolates causing abscesses.

Hyperviscosity phenotype, virulence, and drug resistance genes and capsular serotypes ALL N = 169 (%) T6SS-negative N = 108(%) T6SS-positive N = 61 (%) p.overall
Hyperviscosity phenotype 81 (47.93) 53 (49.07) 28 (45.90) 0.813
HvKp 70 (41.42) 32 (29.63) 38 (62.30) <0.001*
Virulence genes
rmpA 100 (59.17) 54 (50.00) 46 (75.41) 0.002*
rmpA2 81 (47.93) 41 (37.96) 40 (65.57) 0.001*
aerobactin 96 (56.80) 54 (50.00) 42 (68.85) 0.027*
iroB 98 (57.99) 55 (50.93) 43 (70.49) 0.021*
peg344 108 (63.91) 66 (61.11) 42 (68.85) 0.401
mrkD 169 (100.00) 108 (100.00) 61 (100.00) 1.000
wcaG 46 (27.22) 5 (4.63) 41 (67.21) <0.001*
ybts 119(70.41) 72 (66.67) 47 (77.05) 0.213
alls 50 (29.59) 9 (8.33) 41 (67.21) <0.001*
kfu 58 (34.32) 20 (18.52) 38 (62.30) <0.001*
entB 154 (91.12) 99 (91.67) 55 (90.16) 0.961
iutA 101 (59.76) 58 (53.70) 43 (70.49) 0.048
Drug resistance genes
NDM-1 1 (0.59) 1 (0.93) 0 (0.00) 1.000
OXA-48 2 (1.18) 1 (0.93) 1 (1.64) 1.000
TEM 42 (24.85) 29 (26.85) 13 (21.31) 0.538
KPC-2 26 (15.38) 26 (24.07) 0 (0.00) <0.001*
KPC 26 (15.38) 26 (24.07) 0 (0.00) <0.001*
CTX-M 19 (11.24) 9 (8.26) 10 (16.39) 0.180
IMP 0 (0) 0 (0) 0 (0) -
VIM 0 (0) 0 (0) 0 (0) -
SHV 169 (100.00) 109 (100.00) 61 (100.00) 1.000
Capsular serotypes
K1 44 (26.04) 4 (3.70) 40 (65.57) <0.001
K2 36 (21.30) 35 (32.41) 1 (1.64) <0.001
K5 2 (1.18) 2 (1.86) 0 (0.00) 0.537
K20 3 (1.78) 3 (2.78) 0 (0.00) 0.554
K54 2 (1.18) 2 (1.85) 0 (0.00) 0.537
K57 5 (2.96) 3 (2.78) 2 (3.28) 1.000
K64 19 (11.24) 19 (17.59) 0 (0.00) 0.001

p < 0.05 was considered to be statistically significant. Statistically significant values are identified in boldface.